attenuates colonic inflammation in mice with dextran sulphate sodium-induced colitis. Clin Exp Immunol 151: 165173. 6. Kang JS, Yoon YD, Cho IJ, Han MH, Lee CW, et al. Glabridin, an isoflavan from licorice root, inhibits inducible nitric-oxide synthase expression and improves survival of mice in experimental model of septic shock. J Pharmacol Exp Ther 312: 11871194. 7. Yu XQ, Xue CC, Zhou ZW, Li CG, Du YM, et al. In vitro and in vivo neuroprotective impact and mechanisms of glabridin, a major active isoflavan from Glycyrrhiza glabra. Life Sci 82: 6878. 8. Tamir S, Eizenberg M, Somjen D, Stern N, Shelach R, et al. Estrogenic and antiproliferative properties of glabridin from licorice in human breast cancer cells. Cancer Res 60: 57045709. 9. Hsu YL, Wu LY, Hou MF, Tsai EM, Lee JN, et al. Glabridin, an isoflavan from licorice root, inhibits migration, invasion and angiogenesis of MDA-MB-231 human breast adenocarcinoma cells by inhibiting focal adhesion kinase/Rho signaling pathway. Mol Nutr Meals Res 55: 318327. 10. Cohen MM, Jr. TGF beta/Smad signaling system and its pathologic correlates. Am J Med Genet A 116A: 110. 11. Inagaki Y, Okazaki I Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis. Gut 56: 284292. 12. Vittal R, Fan L, Greenspan DS, Mickler EA, Gopalakrishnan B, et al. IL17 induces form V collagen overexpression and EMT through TGF-beta-dependent pathways in obliterative bronchiolitis. Am J Physiol Lung Cell Mol Physiol 304: L401414. 13. Jia Q, Zhang X, Deng T, Gao J Constructive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90CD133 liver cancer stem cells. Cell Reprogram 15: 143150. 14. Bueno L, de Alwis DP, Pitou C, Yingling J, Lahn M, et al. Semimechanistic modelling in the tumour development inhibitory effects of LY2157299, a brand new form I receptor TGF-beta kinase antagonist, in mice. Eur J Cancer 44: 142 150. 15. Zhong Z, Carroll KD, Policarpio D, Osborn C, Gregory M, et al. Antitransforming growth factor beta receptor II antibody has therapeutic efficacy against key tumor growth and metastasis by means of multieffects on cancer, stroma, and immune cells. Clin Cancer Res 16: 11911205. 16. Bhola NE, Balko JM, Dugger TC, Kuba MG, Sanchez V, et al. TGFbeta inhibition enhances chemotherapy action against triple-negative breast cancer. J Clin Invest 123: 13481358. 17. Ji J, Wang XW Clinical implications of cancer stem cell biology in hepatocellular carcinoma. Semin Oncol 39: 461472. 18. Yamashita T, Honda M, Nakamoto Y, Baba M, Nio K, et al. Discrete nature of EpCAM+ and CD90+ cancer stem cells in human hepatocellular carcinoma. Hepatology 57: 14841497. 19. Song YJ, Zhang SS, Guo XL, Sun K, Han ZP, et al. Autophagy contributes towards the survival of CD133+ liver cancer stem cells in the hypoxic and nutrient-deprived tumor microenvironment. Cancer Lett 339: 7081. 20. Liu W, Feng JQ, Shen XM, Wang HY, Liu Y, et al. Two stem cell markers, ATP-binding cassette, G2 subfamily and BMI-1, predict the transformation of oral leukoplakia to cancer: a long-term follow-up study. Cancer 118: 16931700. 21. Koleske AJ, Baltimore D, Lisanti MP Reduction of caveolin and caveolae in oncogenically transformed cells. Proc Natl Acad Sci U S A 92: 13811385. 22. Tang Y, Kitisin K, Jogunoori W, Li C, Deng CX, et al. Progenitor/stem cells give rise to liver cancer as a consequence of aberrant TGF-beta and IL-6 signaling. Proc Natl Acad Sci U S A 105: 58-49-1 site 24452450. 23. Brandl M, Seidler B, Haller F, Adamski J, Schmid RM, et al. IKKa